107573-28-4 Usage
General Description
2,6-anhydro-3-deoxyoctonate is a chemical compound that belongs to the family of octonic acids. This molecule is an important intermediate in the biosynthesis pathway of certain bacteria, specifically in the production of lipopolysaccharides, which are crucial for the outer membrane of gram-negative bacteria. Additionally, 2,6-anhydro-3-deoxyoctonate is also a key component in the creation of the cell wall of these bacteria. 2,6-anhydro-3-deoxyoctonate plays a significant role in the structural integrity and function of gram-negative bacteria, making it an important target for research in the development of new antibiotics and antimicrobial agents.
Check Digit Verification of cas no
The CAS Registry Mumber 107573-28-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,5,7 and 3 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 107573-28:
(8*1)+(7*0)+(6*7)+(5*5)+(4*7)+(3*3)+(2*2)+(1*8)=124
124 % 10 = 4
So 107573-28-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H14O8/c9-2-3-5(12)6(13)7(14)8(15,16-3)1-4(10)11/h3,5-7,9,12-15H,1-2H2,(H,10,11)/t3-,5-,6+,7+,8?/m1/s1
107573-28-4Relevant articles and documents
Template-directed intramolecular C-glycosidation. Formation of tetrahydrofurans and application to the synthesis of a higher-order sugar
Craig, Donald,Pennington, Mark W.,Warner, Peter
, p. 13495 - 13512 (2007/10/03)
Cation-mediated cyclisation reactions of silyl enol ether-containing thioglycosides give bicyclic ketotetrahydrofurans. Cyclisation of an analogous 3-phenyl-2-propenyl ether-containing substrate gives an intermediate in the total synthesis of the higher-order sugar 2,3-dideoxy-D- manno-2-octulopyranosonic acid.
Template-directed intramolecular C-glycosidation. Total synthesis of 2,3-dideoxy-D-manno-2-octulopyranosonic acid
Craig, Donald,Pennington, Mark W.,Warner, Peter
, p. 5815 - 5818 (2007/10/02)
The total synthesis of the KDO-inhibitor 2,3-dideoxy-D-manno-2-octulopyranosonic acid (2-deoxy-KDO) starting from TBDPS-protected (S)-glycidol and 3,3-dimethoxy-1-(phenylsulfonyl)-propane is described. The key steps are silver(I) trifluoromethylsulfonate-